Wright claims US first for allograft bone graft pellets:
This article was originally published in Clinica
Executive Summary
The US FDA has given Wright Medical the go-ahead to market what promises to be an improved version of its Osteoset bone graft substitute. The Osteoset calcium sulfate pellets are now available in a form that contains human demineralised bone matrix (DBM) proteins. Osteoset with DBM have been shown to form natural bone architecture more rapidly than Osteoset calcium sulfate pellets alone, says the Arlington, Tennessee firm. Osteoset DBM joins Wright's Allomatrix putty - which received regulatory clearance in March - as the first FDA-cleared allograft-containing bone void fillers to become available in the US, the company claims.